The use of formulations and at least one anti-cancer component of use as well as low-molecular-weight RNA fragment of the formulation of low-molecular-weight RNA fragment

• 收藏
• 分享

专利权人:

インターナショナル;リサーチ，インコーポレーテッド;モレキュラー インターナショナル リサーチ,インコーポレーテッド;モレキュラー

发明人:

ベルジャンスキ，シルビエ,ハル，ジョン,ベルジャンスキ,シルビエ,ハル,ジョン

申请号：

JP2009534661

公开号：

JP5745767B2

申请日:

2007.10.26

申请国别(地区):

JP

年份:

2015

代理人:

摘要：

This invention provides therapeutic treatments that prevent or ameliorate thrombocytopenia based on administration of small RNA fragments. More specifically, this invention provides an improved chemotherapeutic regimen that prevents or ameliorates bone marrow suppression and thrombocytopenia induced by anti-cancer drugs, wherein the chemotherapeutic regimen incorporates administration of small RNA fragments. Further, the present invention provides a therapeutic treatment for thrombocytopenia associated with immune disorders known as Immune Thrombocytopenic Purpura based on administration of small RNA fragments.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/